Safety and Tumoricidal Effect of Low Dose Temoporfin Photodynamic Therapy in Patients With Inoperable Bile Duct Cancers (Foscan® Study)
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2017
At a glance
- Drugs Temoporfin (Primary)
- Indications Adenocarcinoma; Cholangiocarcinoma
- Focus Adverse reactions
- 20 Apr 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2019.
- 20 Apr 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2019.
- 29 Dec 2016 New trial record